Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 91,620 shares at $46.68 ($4.3M) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Open-market sale of $4.3M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.84 | 11,047 | $506K | 11.8% |
| 2 | $45.84 | 11,047 | $506K | 11.8% |
| 3 | $46.68 | 5,633 | $263K | 6.1% |
| 4 | $46.68 | 5,633 | $263K | 6.1% |
| 5 | $46.68 | 1,200 | $56K | 1.3% |
| 6 | $47.64 | 2,000 |
| $95K |
| 2.2% |
| 7 | $48.52 | 13,480 | $654K | 15.2% |
| 8 | $48.52 | 13,480 | $654K | 15.2% |
| 9 | $45.60 | 7,647 | $349K | 8.1% |
| 10 | $45.60 | 7,647 | $349K | 8.1% |
| 11 | $46.69 | 3,773 | $176K | 4.1% |
| 12 | $46.69 | 3,773 | $176K | 4.1% |
| 13 | $47.75 | 4,360 | $208K | 4.8% |
| 14 | $48.54 | 900 | $44K | 1.0% |
| Total | $46.93 avg | 91,620 | $4.3M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |